Literature DB >> 29596551

Thyroidectomy Practice After Implementation of the 2015 American Thyroid Association Guidelines on Surgical Options for Patients With Well-Differentiated Thyroid Carcinoma.

Nir Hirshoren1, Kira Kaganov2, Jeffrey M Weinberger1, Benjamin Glaser3, Beatrice Uziely4, Ido Mizrahi2, Ron Eliashar1, Haggi Mazeh2.   

Abstract

IMPORTANCE: The recommended extent of surgery for well-differentiated thyroid carcinoma has been modified considerably in the updated 2015 American Thyroid Association guidelines published in January 2016. To date, the changes in clinical practice after publication of these new guidelines have not been demonstrated.
OBJECTIVE: The aim of this study was to evaluate clinical practice changes associated with implementation of the updated guidelines on the surgical procedure rates of total thyroidectomy, thyroid lobectomy, and completion thyroidectomy at a single tertiary medical center. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective cohort study of 169 patients at the Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Patients with pathologically proved, well-differentiated thyroid carcinoma who underwent surgery between January 1, 2013, and December 31, 2014, were compared with patients who underwent surgery from January 1 to December 31, 2016. A total of 434 thyroidectomy procedures were performed during the study period, and 251 had pathologically proved, well-differentiated thyroid carcinoma. Patients with tumors larger than 4 cm, involved lymph nodes, or bilateral nodules were excluded. MAIN OUTCOMES AND MEASURES: Primary outcomes were the rate of up-front total thyroidectomy vs lobectomy and the rates of completion thyroidectomy before and after the implementation of the new guidelines.
RESULTS: Of the 169 patients in the final analysis, 118 (69.8%) were included from 2013 to 2014 and 51 (30.2%) in 2016. The mean (SD) age for the entire cohort was 44 (13.8) years, and 129 (76.3%) were women. Up-front total thyroidectomy was performed in 72 of 118 patients (61.0%) prior to the 2015 American Thyroid Association guidelines and 16 of 51 (31.4%) following their implementation (odds ratio, 0.29; 95% CI, 0.14-0.59). The rate of completion thyroidectomy also significantly decreased between these periods (73.9% vs 20.0%; odds ratio, 0.09; 95% CI, 0.04-0.19). CONCLUSIONS AND RELEVANCE: The updated 2015 American Thyroid Association guidelines implementation was associated with a significant decrease in the rates of both up-front total thyroidectomy and completion thyroidectomy. According to these findings, only 1 of 5 patients who undergoes thyroid lobectomy will require a completion procedure.

Entities:  

Mesh:

Year:  2018        PMID: 29596551      PMCID: PMC5876852          DOI: 10.1001/jamaoto.2018.0042

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  14 in total

1.  Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.

Authors:  Briseis Aschebrook-Kilfoy; Mary H Ward; Mona M Sabra; Susan S Devesa
Journal:  Thyroid       Date:  2010-12-27       Impact factor: 6.568

2.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

3.  Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.

Authors:  Wouter P Kluijfhout; Jesse D Pasternak; Frederick T Drake; Toni Beninato; Wen T Shen; Jessica E Gosnell; Insoo Suh; Liu C; Quan-Yang Duh
Journal:  Surgery       Date:  2016-11-14       Impact factor: 3.982

4.  The Bethesda System for Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  Minimally invasive follicular thyroid cancer: treat as a benign or malignant lesion?

Authors:  Aaron Robinson; David Schneider; Rebecca Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2016-08-20       Impact factor: 2.192

6.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.

Authors:  Yuri E Nikiforov; Raja R Seethala; Giovanni Tallini; Zubair W Baloch; Fulvio Basolo; Lester D R Thompson; Justine A Barletta; Bruce M Wenig; Abir Al Ghuzlan; Kennichi Kakudo; Thomas J Giordano; Venancio A Alves; Elham Khanafshar; Sylvia L Asa; Adel K El-Naggar; William E Gooding; Steven P Hodak; Ricardo V Lloyd; Guy Maytal; Ozgur Mete; Marina N Nikiforova; Vania Nosé; Mauro Papotti; David N Poller; Peter M Sadow; Arthur S Tischler; R Michael Tuttle; Kathryn B Wall; Virginia A LiVolsi; Gregory W Randolph; Ronald A Ghossein
Journal:  JAMA Oncol       Date:  2016-08-01       Impact factor: 31.777

Review 7.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

8.  Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4 cm Well-Differentiated Thyroid Cancer.

Authors:  Wouter P Kluijfhout; Jesse D Pasternak; James Lim; Julie S Kwon; Menno R Vriens; Orlo H Clark; Wen T Shen; Jessica E Gosnell; Insoo Suh; Quan-Yang Duh
Journal:  Thyroid       Date:  2016-05-20       Impact factor: 6.568

9.  Extent of surgery affects survival for papillary thyroid cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti; Cord Sturgeon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

10.  Less is More: The Impact of Multidisciplinary Thyroid Conference on the Treatment of Well-Differentiated Thyroid Carcinoma.

Authors:  Maureen D Moore; Emily Postma; Katherine D Gray; Timothy M Ullmann; James R Hurley; Stanley Goldsmith; Vivian R Sobel; Aaron Schulman; Theresa Scognamiglio; Paul J Christos; Erin Hassett; Jessica Luick; Dana Whitehall; Rasa Zarnegar; Thomas J Fahey
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

View more
  7 in total

1.  Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.

Authors:  Whitney Sutton; Philip K Crepeau; Joseph K Canner; Shkala Karzai; Dorry L Segev; Aarti Mathur
Journal:  Am J Surg       Date:  2022-02-01       Impact factor: 3.125

2.  Systematic Review of Recurrence Rate after Hemithyroidectomy for Low-Risk Well-Differentiated Thyroid Cancer.

Authors:  Samuel Chan; Katarina Karamali; Anna Kolodziejczyk; Georgios Oikonomou; John Watkinson; Vinidh Paleri; Iain Nixon; Dae Kim
Journal:  Eur Thyroid J       Date:  2020-01-28

3.  Trends in Thyroid Surgery and Guideline-Concordant Care in the United States, 2007-2018.

Authors:  Asmae Toumi; Catherine DiGennaro; Vahab Vahdat; Mohammad S Jalali; G Scott Gazelle; Jagpreet Chhatwal; Rachel R Kelz; Carrie C Lubitz
Journal:  Thyroid       Date:  2021-01-18       Impact factor: 6.506

4.  TERT Promoter Mutations Are an Independent Predictor of Distant Metastasis in Middle Eastern Papillary Thyroid Microcarcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Kaleem Iqbal; Zeeshan Qadri; Saeeda O Ahmed; Maha Al-Rasheed; Ahmed A AlQatie; Saif S Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-11       Impact factor: 5.555

5.  Higher EU-TIRADS-Score Correlated with BRAF V600E Positivity in the Early Stage of Papillary Thyroid Carcinoma.

Authors:  Karolina Skubisz; Joanna Januszkiewicz-Caulier; Patrycja Cybula; Elwira Bakuła-Zalewska; Krzysztof Goryca; Agnieszka Paziewska; Filip Ambrożkiewicz; Kosma Woliński; Michał Mikula; Jerzy Ostrowski; Marek Dedecjus
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

Review 6.  Thyroid Lobectomy for Low to Intermediate Risk Differentiated Thyroid Cancer.

Authors:  Dana M Hartl; Joanne Guerlain; Ingrid Breuskin; Julien Hadoux; Eric Baudin; Abir Al Ghuzlan; Marie Terroir-Cassou-Mounat; Livia Lamartina; Sophie Leboulleux
Journal:  Cancers (Basel)       Date:  2020-11-06       Impact factor: 6.639

7.  Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.

Authors:  Sandeep Kumar Parvathareddy; Abdul K Siraj; Zeeshan Qadri; Saeeda O Ahmed; Felisa DeVera; Saif Al-Sobhi; Fouad Al-Dayel; Khawla S Al-Kuraya
Journal:  Endocr Connect       Date:  2022-02-16       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.